文献速递胸部技术与安全CT

多水平干预提高肺癌筛查中低剂量CT参与率(Empower LCS):单臂先导性可行性临床试验

A Multilevel Approach to Improve Participation in Low-Dose CT for Lung Cancer Screening (Empower LCS): A Single-Arm Pilot Feasibility Clinical Trial.
PubMed 文献 · J Am Coll Radiol · 2025-11-13

本研究为单臂先导性可行性临床试验,纳入70例符合2021年美国预防服务工作组肺癌筛查标准的50至80岁患者,评估多水平干预(决策辅助、文本提醒、初级保健提供者通知、经济困难与健康相关社会需求支持)的可行性和初步效果。6个月时71.4%与初级保健提供者讨论了肺癌筛查,51.4%收到低剂量CT医嘱,27.1%完成筛查,完成率超过全国平均16%(P=0.01)。干预可行并提高了筛查参与度,但仅半数收到医嘱者完成筛查,提示需加强导航。

要点

  • 6个月时27.1%(19/70)完成低剂量CT筛查,完成率超过全国平均16%(P=0.01)。
  • 收到低剂量CT医嘱者中仅52.8%完成筛查,提示需加强导航。
  • 常见筛查障碍包括费用担忧(40%,28/70)和害怕发现异常(34.3%,24/70)。

核心结论

  • Empower LCS干预可行并提高了肺癌筛查参与度,但仅半数收到医嘱者完成筛查,提示需加强导航。

研究设计与样本

  • 单臂先导性可行性临床试验,纳入70例50至80岁符合2021年美国预防服务工作组肺癌筛查标准的患者,通过病历和调查评估6个月时的筛查结局。

诊断标准与关键数值

  • 6个月时71.4%(50/70)与初级保健提供者讨论了肺癌筛查。
  • 6个月时51.4%(36/70)收到低剂量CT医嘱。
  • 6个月时27.1%(19/70)完成筛查,占收到医嘱者的52.8%。
  • 完成率超过全国平均16%(P=0.01)。

临床应用与阅片要点

  • 作者认为干预可行并提高了肺癌筛查参与度,但仅半数收到医嘱者完成筛查,提示需加强导航。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: Lung cancer screening (LCS) uptake remains low nationally. We evaluated the feasibility and preliminary efficacy of a multilevel intervention to improve LCS uptake in a pilot trial.

METHODS: Eligible patients were 50 to 80 and met 2021 United States Preventive Services Task Force LCS criteria. The Empower LCS intervention included (1) a decision aid; (2) a text reminder to encourage LCS discussion with primary care providers (PCPs); (3) PCP notifications on eligibility and barriers, and (4) financial hardship and health-related social needs support. Screening outcomes (LCS discussions, orders, and completion) at 6 months were assessed using medical records and surveys. Changes in LCS knowledge and health beliefs were assessed with surveys.

RESULTS: In all, 70 patients enrolled (mean age: 62.5 ± 6.3; 70% male; 1.4% Black, 18.6% Asian, 44.3% White, 35.7% other); 45.7% were Hispanic, and 41% were current smokers. Common LCS barriers included cost concerns (40%, 28 of 70) and fear of finding something wrong (34.3%, 24 of 70). All received the decision aid, text reminder, and PCP alert. Of the patients, 72.9% reported financial hardship or health-related social needs and received support. At 6 months, 71.4% (50 of 70) discussed LCS with their PCP, 51.4% (36 of 70) received low-dose CT orders, and 27.1% (19 of 70) completed screening (52.8% of those with order). Completion exceeded the national average of 16% (P = 0.01). Knowledge and perceived severity changed significantly (knowledge: from 1.91 to 2.67, P = .01; severity: from 16.3 to 18.1, P = .0003). No significant changes were observed in perceived barriers or self-efficacy.

CONCLUSION: The Empower LCS intervention was feasible and improved LCS uptake. However, only half of those with LCS order, completed screening, suggesting the need for enhanced navigation.

来源:J Am Coll Radiol,查看原文。版权归原作者所有。

引用

  1. Shojazadeh A, Kao R, Pham T, et al. A Multilevel Approach to Improve Participation in Low-Dose CT for Lung Cancer Screening (Empower LCS): A Single-Arm Pilot Feasibility Clinical Trial. J Am Coll Radiol. 2025. PMID: 41241060. doi:10.1016/j.jacr.2025.11.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。